Substance Balance Study of [14C]ZX-7101A in Healthy Adult Male Subjects in China
Clinical trial NCT05720091 · COMPLETED
Trial details
- NCT number
- NCT05720091
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-14
- Primary completion
- 2023-03-20
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.